LONDON--(BUSINESS WIRE)--Technavio has been monitoring the POC HbA1C testing market and it is poised to grow by USD 203.16 million during 2020-2024, progressing at a CAGR of almost 9% during the ...

DUBLIN, April 14, 2020 /PRNewswire/ -- The "Point of Care Diagnostics Market Size, Share & Trends Analysis Report by Product (Glucose Testing, Blood Gas/ Electrolytes, Cancer Marker), by End Use ...

The FDA final guidances for point-of-care (POC) and home-use glucose monitors might not have given industry everything it wanted compared to the draft guidances, but the agency said in a webinar that ...

The EMEA point-of-care diagnostics market presents opportunities through rapid diagnostic innovations, especially in ...

Quo-Lab meets strict international quality targets – confirming it fit for purpose for diabetes testing The study aimed to evaluate the four POC HbA1c instruments according to Clinical and Laboratory ...

Dublin, May 14, 2018 (GLOBE NEWSWIRE) -- The "The Worldwide Market for Point-of-Care (POC) Testing (Infectious Disease Testing, POC Cancer Tests, Rapid Coagulation, Urine Testing, Lipid Tests, ...

EKF Diagnostics, the global in vitro diagnostics company, announces that it has signed a three-year distribution agreement with Tosoh Europe N.V. for the distribution of its Quo-Test ® HbA1c ...

Study of the evolution of PoC testing shows that technology development has progressed to be close to laboratory quality and to meet the clinical needs. In the past, simple chemical test methods were ...

The U.S. FDA’s effort to compile a guidance for prescription, point-of-care (POC) blood glucose meter (BGM) test systems seems to show that guidances can be as iterative as the devices they govern.

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the POC HbA1C testing market and it is poised to grow by USD 203.16 million during 2020-2024, progressing at a CAGR of almost 9% during the ...